CCI
KYTH

Columbus Circle Investors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Columbus Circle Investors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,242
Closed -$467K – 349
2014
Q3 		$467K Buy
14,242
+4,156
+41% +$146K ﹤0.01% 251
2014
Q2 		$387K Buy
+10,086
New +$352K ﹤0.01% 271
2013
Q4 		– Sell
-234,269
Closed -$10.7M – 373
2013
Q3 		$10.7M Buy
+234,269
New +$7.01M 0.08% 220

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Columbus Circle Investors's KYTH Position: Q4 2014 in Review

Columbus Circle Investors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 14,242 shares — an estimated $467K sold.

Columbus Circle Investors first reported a position in KYTH in Q3 2013 and held it in 3 quarters. The position peaked at $10.7M in Q3 2013. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

  • Columbus Circle Investors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 14,242 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $467K.
  • Columbus Circle Investors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 3 quarters.
  • Columbus Circle Investors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $10.7M in Q3 2013.
  • 106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Columbus Circle Investors's 13F filing for Q4 2014, filed 5 Feb 2015.